Asthma, Chest Disorder, Pain, Pulmonary Disease
Conditions
Keywords
Subcutaneous heparin injection, pain, non-pharmacological method, vibration
Brief summary
Aim: The aim of this research will to examine the effect of the local vibration technique applied to the injection site during subcutaneous low molecular weight heparin (LMWH) injection. Methods: The patients will randomly assigned to an experimental (vibration) group , a placebo control group, and a nonintervention control group. Participants in the experimental group will give slight vibration to the injection site before the injection will administered; for participants in the placebo group, the device will placed on the injection site but with the vibration button kept switched off, while for the nonintervention control group, routine subcutaneous low molecular weight heparin injection will administered. The level of pain felt by the participants during the administration of the injection will assess with a visual analog scale.
Interventions
DEVICEVibration
The device was used to provide vibration with the participants in this group. This device, designed as a combination of cold application and local vibration to reduce pain experienced during invasive procedures, is frequently chosen for all age groups.
OTHERPlacebo
The device was used with participants in this group. The device, at room temperature, was placed by the researcher 5cm proximal to the injection site before the injection was performed. With participants in this group, the device was placed on the procedure site, but no vibration was made. The device was held on the participants for one minute before the injection and throughout the procedure, with the vibration switched off.
Sponsors
Uludag University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* being over the age of 18 * having a doctor's prescription for subcutaneousheparin 0.6 mL treatment with a ready-to-use syringe and not yet having begun treatment * having no coagulation disorder * having no disorder which could affect pain perception, * having no incision, lipodystrophy or finding of infection at the injection site, * having no communication problem, and voluntarily agreeing to participate in the research
Exclusion criteria
* being under the age of 18 * having diabetes mellitus * peripheral vascular disease, etc. which could affect the perception of pain * not being conscious, refusing to participate in the research or opting to leave the study at any point.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain intensity in mm | 6 months | A 10-cm vertical VAS will used to evaluate the severity of pain felt by the individuals during the procedure. One end indicated lack of pain and the other the most severe pain possible. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| weight | 6 months | weight in kilograms |
| height | 6 months | height in meters |
Countries
Turkey (Türkiye)
Outcome results
None listed